Multicenter Randomized Controlled Trial of Combination Antiemetic Therapy With Aprepitant / Fosaprepitant in Patients With Colorectal Cancer Receiving Oxaliplatin-based Chemotherapy
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aprepitant (Primary) ; Fosaprepitant (Primary) ; Dexamethasone; Dexamethasone; Serotonin 3 receptor antagonists
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- Acronyms SENRI
- 21 Jan 2017 Results of subgroup analysis of SENRI trial (n=370) presented at the 2017 Gastrointestinal Cancers Symposium
- 04 Jul 2015 Results presented at the 17th World Congress on Gastrointestinal Cancer.
- 28 Apr 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health record).